ArticleDrug metabolism and disposition: the biological fate of chemicals2013

Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status.

Xi-Ling Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.